Amgen Inc. v. Alkem Laboratories Ltd. > Summary
Court Case Number 1:17-cv-00815
Filing Date Jun 23, 2017
Termination Date May 9, 2018
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesGregory M. Sleet
Plaintiff
Defendant
Plaintiff Attorneys
7Amgen
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Amgen
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Amgen
Attorney Name: John D. Murnane
Venable
Amgen
Attorney Name: Joshua I. Rothman
Venable
Amgen
Attorney Name: Alicia A. Russo
Venable
Amgen
Attorney Name: Wendy A. Whiteford
Amgen
Amgen
Attorney Name: Lois Marie Kwasigroch
Amgen
Defendant Attorneys
10Alkem Laboratories Ltd.
Attorney Name: Gary Ji
FisherBroyles
Alkem Laboratories Ltd.
Attorney Name: Joseph M. Manak
FisherBroyles
Alkem Laboratories Ltd.
Attorney Name: Francis J. Murphy Jr.
Murphy & Landon, P.A.
Alkem Laboratories Ltd.
Attorney Name: Benjamin J. Schladweiler
Greenberg Traurig LLP
Alkem Laboratories Ltd.
Attorney Name: Joseph Schramm III
FisherBroyles
Alkem Laboratories Ltd.
Attorney Name: Scott Bennett Feder
Locke Lord
Alkem Laboratories Ltd.
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Alkem Laboratories Ltd.
Attorney Name: Gurpreet Singh Walia
FisherBroyles
Attorney Name: Nicholas D. Mozal
Attorney Name: Scott Bennett Feder
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09375405 | Rapid dissolution formulation of a calcium receptor-active compound | Jun 28, 2016 |
